Table 3. Expression levles of the seven miRNAs and their diagnostic significace in sputum of 36 lung adenocarcinoma patients and 36 healthy controls.
MiRNA | Mean (SD) in cancer patients | Mean (SD) in healthy controls | P* | AUC* (SE) | Cutoffs | Sensitivity (%) | Specificity (%) |
---|---|---|---|---|---|---|---|
MiR-486 | 0.051 (0.034) | 0.182 (0.167) | <0.001 | 0.834 (0.034) | 0.108 | 66.9 | 79.4 |
MiR-126 | 0.083 (0.087) | 0.258 (0.198) | <0.001 | 0.824 (0.032) | 0.156 | 67.2 | 73.8 |
MiR-145 | 0.132 (0.073) | 0.351 (0.297) | <0.001 | 0.807 (0.031) | 0.226 | 59.5 | 82.9 |
MiR-21 | 8.217 (5.680) | 2.730 (2.354) | <0.001 | 0.846 (0.038) | 5.664 | 72.6 | 79.2 |
MiR-182 | 7.463 (5.822) | 2.212 (1.164) | <0.001 | 0.825 (0.033) | 4.973 | 64.3 | 79.5 |
MiR-200b | 6.623 (5.367) | 2.931 (1.285) | <0.001 | 0.823 (0.036) | 4.838 | 62.9 | 78.5 |
MiR-375 | 7.207 (6.012) | 2.894 (1.766) | <0.001 | 0.822 (0.035) | 5.267 | 63.9 | 80.6 |
Abbreviations: AUC, the area under receiver operating characteristic curve; SD, standard deviation; SE, standard error.
Both the P value and AUC were obtained using the U6-normalized values